The results may provide novel insights into the role of CD44-/CD24- tumor cells in delayed breast cancer metastasis and into the potential use of CD44-/CD24- cells as a biomarker to predict survival and metastasis in breast cancer patients. Here, CD24 is linked to breast carcinoma.